Algert Global LLC Decreases Stake in Select Medical Holdings Co. (NYSE:SEM)

Algert Global LLC lessened its holdings in Select Medical Holdings Co. (NYSE:SEM) by 25.9% during the second quarter, Holdings Channel.com reports. The institutional investor owned 88,591 shares of the health services provider’s stock after selling 30,919 shares during the quarter. Algert Global LLC’s holdings in Select Medical were worth $3,106,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of SEM. Hexagon Capital Partners LLC boosted its position in Select Medical by 528.7% in the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after purchasing an additional 645 shares during the last quarter. Transcendent Capital Group LLC bought a new stake in shares of Select Medical during the 2nd quarter worth $35,000. Canada Pension Plan Investment Board purchased a new position in shares of Select Medical in the 2nd quarter worth about $39,000. Fidelis Capital Partners LLC bought a new position in Select Medical during the first quarter valued at about $47,000. Finally, DekaBank Deutsche Girozentrale purchased a new stake in Select Medical during the second quarter worth about $60,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have recently weighed in on SEM shares. Benchmark reissued a “buy” rating and set a $48.00 target price on shares of Select Medical in a research report on Friday, September 6th. Bank of America initiated coverage on Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective on the stock. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $39.00.

Select Medical Price Performance

SEM opened at $34.06 on Wednesday. The firm has a 50-day moving average price of $35.12 and a 200-day moving average price of $33.31. Select Medical Holdings Co. has a twelve month low of $21.28 and a twelve month high of $40.50. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The company has a market capitalization of $4.43 billion, a price-to-earnings ratio of 16.22, a PEG ratio of 2.14 and a beta of 1.42.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01). The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a net margin of 3.91% and a return on equity of 17.50%. The firm’s quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.61 earnings per share. Equities analysts expect that Select Medical Holdings Co. will post 2.03 EPS for the current year.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th were paid a $0.125 dividend. The ex-dividend date was Wednesday, August 14th. This represents a $0.50 annualized dividend and a yield of 1.47%. Select Medical’s dividend payout ratio is currently 23.81%.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.